• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Oscar Health Inc. (Amendment)

    2/14/24 4:30:04 PM ET
    $OSCR
    Medical Specialities
    Health Care
    Get the next $OSCR alert in real time by email
    SC 13G/A 1 d758408dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Oscar Health, Inc.

    (Name of Issuer)

    Class A Common Stock, $0.00001 par value per share

    (Title of Class of Securities)

    687793109

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures IV, LP

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    4,564,404 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    4,564,404 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,564,404 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    2.4% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    PN

     

    (1)

    This statement on Schedule 13G is filed by Khosla Ventures IV, LP (“KV IV”), Khosla Ventures IV (CF), LP (“KV IV (CF)”), Khosla Ventures VI, LP (“KV VI”), Khosla Ventures Opportunity I, LP (“KV Opp I”), Khosla Ventures Associates IV, LLC (“KVA IV”), Khosla Ventures Associates VI, LLC (“KVA VI”), Khosla Ventures Opportunity Associates I, LLC (“KVOA I”), VK Services, LLC (“VK Services”) and Vinod Khosla (“Khosla,” together with KV IV, KV IV (CF), KV VI, KV Opp I, KVA IV, KVA VI, KVOA I and VK Services collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares are owned by KV IV. The general partner of KV IV is KVA IV. VK Services is the sole manager of KVA IV. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV, and each of KVA IV, VK Services and Khosla may be deemed to have indirect beneficial ownership of such shares.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures IV (CF), LP

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    291,808 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    291,808 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    291,808 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.2% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    PN

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares are owned by KV IV (CF). The general partner of KV IV (CF) is KVA IV. VK Services is the sole manager of KVA IV. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV (CF), and each of KVA IV, VK Services and Khosla may be deemed to have indirect beneficial ownership of such shares.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures VI, LP

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    1,476,809 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    1,476,809 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,476,809 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.8% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    PN

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares are owned by KV VI. The general partner of KV VI is KVA VI. VK Services is the sole manager of KVA VI. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA VI possesses power to direct the voting and disposition of the shares owned by KV VI, and each of KVA VI, VK Services and Khosla may be deemed to have indirect beneficial ownership of such shares.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures Opportunity I, LP

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    515,762 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    515,762 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    515,762 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.3% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    PN

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares are owned by KV Opp I. The general partner of KV Opp I is KVOA I. VK Services is the sole manager of KVOA I. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVOA I possesses power to direct the voting and disposition of the shares owned by KV Opp I, and each of Khosla, VK Services and KVOA I may be deemed to have indirect beneficial ownership of such shares.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures Associates IV, LLC

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    4,856,212 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    4,856,212 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,856,212 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    2.5% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    OO

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares beneficially owned by KVA IV are comprised of Class A Common Stock held by KV IV and KV IV (CF). The general partner of KV IV and KV IV (CF) is KVA IV. VK Services is the sole manager of KVA IV. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV and KV IV (CF), and each of Khosla, VK Services and KVA IV may be deemed to have indirect beneficial ownership of such shares. KVA IV holds no shares of the Issuer directly.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures Associates VI, LLC

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    1,476,809 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    1,476,809 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    1,476,809 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.8% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    OO

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares beneficially owned by KVA VI are comprised of Class A Common Stock held by KV VI. The general partner of KV VI is KVA VI. VK Services is the sole manager of KVA VI. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA VI possesses power to direct the voting and disposition of the shares owned by KV VI, and each of Khosla, VK Services and KVA VI may be deemed to have indirect beneficial ownership of such shares. KVA VI holds no shares of the Issuer directly.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Khosla Ventures Opportunity Associates I, LLC

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    515,762 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    515,762 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    515,762 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.3% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    OO

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares beneficially owned by KVOA I are comprised of Class A Common Stock held by KV Opp I. The general partner of KV Opp I is KVOA I. VK Services is the sole manager of KVOA I. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVOA I possesses power to direct the voting and disposition of the shares owned by KV Opp I, and each of Khosla, VK Services and KVOA I may be deemed to have indirect beneficial ownership of such shares. KVOA I holds no shares of the Issuer directly.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    VK Services, LLC

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware, United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    8,130,510 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    8,130,510 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    8,130,510 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.3% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    OO

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    1,281,727 of the shares beneficially owned by VK Services are comprised of Class A Common Stock held by VK Services. The remaining shares beneficially owned by VK Services are comprised of shares of Class A Common Stock held by KV IV, KV IV (CF), KV VI and KV Opp I. The general partner of KV IV and KV IV (CF) is KVA IV, the general partner of KV VI is KVA VI and the general partner of KV Opp I is KVOA I. VK Services is the sole manager of KVA IV, KVA VI, and KVOA I. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV and KV IV (CF), and each of Khosla, VK Services and KVA IV may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVA VI possesses power to direct the voting and disposition of the shares owned by KV VI, and each of Khosla, VK Services and KVA VI may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVOA I possesses power to direct the voting and disposition of the shares owned by KV Opp I, and each of Khosla, VK Services and KVOA I may be deemed to have indirect beneficial ownership of such shares.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    CUSIP No: 687793109      

     

    1   

    NAMES OF REPORTING PERSONS

     

    Vinod Khosla

    2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐  (b) ☒ (1)

     

    3   

    SEC USE ONLY

     

    4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5   

    SOLE VOTING POWER

     

    0

       6   

    SHARED VOTING POWER

     

    8,130,510 (2)

       7   

    SOLE DISPOSITIVE POWER

     

    0

       8   

    SHARED DISPOSITIVE POWER

     

    8,130,510 (2)

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    8,130,510 (2)

     10   

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

     11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.3% (3)

     12   

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    IN

     

    (1)

    This statement on Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

    (2)

    All of the shares beneficially owned by Khosla are comprised of Class A Common Stock held by KV IV, KV IV (CF), KV VI, KV Opp I, and VK Services. The general partner of KV IV and KV IV (CF) is KVA IV, the general partner of KV VI is KVA VI and the general partner of KV Opp I is KVOA I. VK Services is the sole manager of KVA IV, KVA VI, and KVOA I. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV and KV IV (CF), and each of Khosla, VK Services and KVA IV may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVA VI possesses power to direct the voting and disposition of the shares owned by KV VI, and each of Khosla, VK Services and KVA VI may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVOA I possesses power to direct the voting and disposition of the shares owned by KV Opp I, and each of Khosla, VK Services and KVOA I may be deemed to have indirect beneficial ownership of such shares. Khosla holds no shares of the Issuer directly.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.


    This Amendment No. 1 to the statement on Schedule 13G (this “Amendment No. 1”) amends and restates the statement on Schedule 13G filed on February 14, 2023 (the “Schedule 13G”).

     

    Item 1(a).

    Name of Issuer:

    Oscar Health, Inc.

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    75 Varick Street

    5th Floor

    New York, NY 10013

     

    Item 2(a).

    Name of Person(s) Filing:

    Khosla Ventures IV, LP (“KV IV”)

    Khosla Ventures IV (CF), LP (“KV IV (CF)”)

    Khosla Ventures VI, LP (“KV VI”)

    Khosla Ventures Opportunity I, LP (“KV Opp I”)

    Khosla Ventures Associates IV, LLC (“KVA IV”)

    Khosla Ventures Associates VI, LLC (“KVA VI”)

    Khosla Ventures Opportunity Associates I, LLC (“KVOA I”)

    VK Services, LLC (“VK Services”)

    Vinod Khosla (“Khosla”)

     

    Item 2(b).

    Address of Principal Business Office:

    Khosla Ventures

    2128 Sand Hill Road

    Menlo Park, California 94025

     

    Item 2(c).

    Citizenship:

     

    KV IV    Delaware, United States of America
    KV IV (CF)    Delaware, United States of America
    KV VI    Delaware, United States of America
    KV Opp I    Delaware, United States of America
    KVA IV    Delaware, United States of America
    KVA VI    Delaware, United States of America
    KVOA I    Delaware, United States of America
    VK Services    Delaware, United States of America
    Khosla    United States of America

     

    Item 2(d).

    Title of Class of Securities:

    Class A Common Stock, par value $0.00001 per share.

     

    Item 2(e).

    CUSIP Number:

    687793109

     

    Item 3.

    If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

    Not applicable.


    Item 4(a).

    Amount Beneficially Owned:

     

    Item 4(b).

    Percent of Class:

     

    Item 4(c).

    Number of shares as to which such persons have:

    The following information with respect to the beneficial ownership of Class A Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2021:

     

    Reporting Persons    Shares Held
    Directly
         Sole
    Voting
    Power
         Shared
    Voting
    Power (1)
         Sole
    Dispositive
    Power
         Shared
    Dispositive
    Power (1)
         Beneficial
    Ownership(1)
         Percent
    of Class (1, 3)
     

    KV IV

         4,564,404        0        4,564,404        0        4,564,404        4,564,404        2.4 % 

    KV IV (CF)

         291,808        0        291,808        0        291,808        291,808        0.2 % 

    KV VI

         1,476,809        0        1,476,809        0        1,476,809        1,476,809        0.8 % 

    KV Opp 1

         515,762        0        515,762        0        515,762        515,762        0.3 % 

    KVA IV

         0        0        4,856,212        0        4,856,212        4,856,212        2.5 % 

    KVA VI

         0        0        1,476,809        0        1,476,809        1,476,809        0.8 % 

    KVOA I

         0        0        515,762        0        515,762        515,762        0.3 % 

    VK Services

         1,281,727        0        8,130,510        0        8,130,510        8,130,510        4.3 % 

    Khosla

         0        0        8,130,510        0        8,130,510        8,130,510        4.3 % 

     

    (1)

    Represents the number of shares of Class A Common Stock and the number of shares of Class A Common Stock issuable upon exercise of options, warrants and other convertible securities that are exercisable within 60 days of the date of this statement on Schedule 13G currently beneficially owned by the Reporting Persons.

    (2)

    All of the shares beneficially owned by VK Services and Khosla are comprised of Class A Common Stock held by KV IV, KV IV (CF), KV VI, KV Opp I, and VK Services. The general partner of KV IV and KV IV (CF) is KVA IV, the general partner of KV VI is KVA VI and the general partner of KV Opp I is KVOA I. VK Services is the sole manager of KVA IV, KVA VI, and KVOA I. Khosla is the managing member of VK Services. Each of Khosla, VK Services and KVA IV possesses power to direct the voting and disposition of the shares owned by KV IV and KV IV (CF), and each of Khosla, VK Services and KVA IV may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVA VI possesses power to direct the voting and disposition of the shares owned by KV VI, and each of Khosla, VK Services and KVA VI may be deemed to have indirect beneficial ownership of such shares. Each of Khosla, VK Services and KVOA I possesses power to direct the voting and disposition of the shares owned by KV Opp I, and each of Khosla, VK Services and KVOA I may be deemed to have indirect beneficial ownership of such shares. Khosla holds no shares of the Issuer directly.

    (3)

    The percentages set forth on the cover sheets are calculated based on 190,815,085 shares of Class A Common Stock as of October 31, 2023 as set forth in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2023.

     

    Item 5.

    Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: ☒

     

    Item 6.

    Ownership of More Than Five Percent on Behalf of Another Person:

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group:

    Not applicable.


    Item 9.

    Notice of Dissolution of Group:

    Not applicable.

     

    Item 10.

    Certifications:

    Not applicable.


    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2024

     

    KHOSLA VENTURES IV, LP
    By:   Khosla Ventures Associates IV, LLC, a Delaware limited liability company and general partner of Khosla Ventures IV, LP
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member
    KHOSLA VENTURES IV (CF), LP
    By:   Khosla Ventures Associates IV, LLC, a Delaware limited liability company and general partner of Khosla Ventures IV (CF), LP
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member
    KHOSLA VENTURES VI, LP
    By:   Khosla Ventures Associates VI, LLC a
    Delaware limited liability company and general Partner of Khosla Ventures VI, LP
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member
    KHOSLA VENTURES OPPORTUNITY I, LP
    By:   Khosla Ventures Opportunity Associates I, LLC a Delaware limited liability company and general Partner of Khosla Ventures Opportunity I, LP
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member


    KHOSLA VENTURES ASSOCIATES IV, LLC
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member
    KHOSLA VENTURES ASSOCIATES VI, LLC
    By:   /s/ Vinod Khosla
      Vinod Khosla, Managing Member
    KHOSLA VENTURES OPPORTUNITY ASSOCIATES I, LLC
    By:   /s/ Vinod Khosla
      Vinod Khosla, Manager
    VK SERVICES, LLC
    By:   /s/ Vinod Khosla
      Vinod Khosla, Manager
    /s/ Vinod Khosla
    Vinod Khosla

    Exhibit(s):

    99.1: Joint Filing Statement

     

    Get the next $OSCR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OSCR

    DatePrice TargetRatingAnalyst
    3/13/2025$20.00 → $16.00Overweight → Equal Weight
    Wells Fargo
    12/10/2024$12.00Underperform
    Jefferies
    11/6/2024$21.00 → $13.50Neutral → Underperform
    BofA Securities
    10/7/2024$23.00Neutral
    UBS
    6/26/2024$25.00Overweight
    Piper Sandler
    5/30/2024$28.00Outperform
    Robert W. Baird
    5/30/2024$25.00 → $21.00Buy → Neutral
    BofA Securities
    3/22/2024$20.00Outperform
    Raymond James
    More analyst ratings

    $OSCR
    Financials

    Live finance-specific insights

    See more
    • Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance

      Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025. "Oscar reported strong financial results in the first quarter," said Mark Bertolini, CEO of Oscar Health. "We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners." Oscar is reaffirming its full year 2025 outlook across all metrics as provided in its financial results press release dated February 4, 2025. First Qu

      5/7/25 6:00:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health, Inc. 2025 First Quarter Earnings Conference Call

      Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless

      4/9/25 8:00:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health Announces Fourth Quarter and Full Year 2024 Results; Introduces Full Year 2025 Outlook

      Reports Adjusted EBITDA and Net Income Profitability for the First Time in Company History For the year ended December 31, 2024: Total Revenue of $9.2 billion, a 56.5% increase year-over-year Medical Loss Ratio of 81.7%, a 10 bps increase year-over-year SG&A Expense Ratio of 19.1%, a 520 bps improvement year-over-year Net income attributable to Oscar of $25.4 million, or $0.10 of diluted earnings per share, a $296.2 million improvement year-over-year Adjusted EBITDA of $199.2 million, an improvement of $244.5 million year-over-year Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, today announced its financial results

      2/4/25 4:05:00 PM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Robinson Elbert O. Jr. sold $410,750 worth of shares (25,000 units at $16.43), decreasing direct ownership by 28% to 64,512 units (SEC Form 4)

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      5/14/25 4:20:39 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Plouffe David

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      4/14/25 4:17:56 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Director Gassen William

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      4/14/25 4:17:43 PM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Thrive Partners Vii Growth Gp, Llc bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      11/22/24 4:33:02 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • Co-Founder and Vice Chairman Kushner Joshua bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      11/22/24 4:29:47 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • Director Thrive Partners Vii Growth Gp, Llc bought $5,444,343 worth of shares (344,522 units at $15.80) (SEC Form 4)

      4 - Oscar Health, Inc. (0001568651) (Issuer)

      11/18/24 5:02:12 PM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Oscar Health Announces Strong Financial Results for First Quarter 2025 And Reaffirms 2025 Guidance

      Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today its financial results for the first quarter ended March 31, 2025. "Oscar reported strong financial results in the first quarter," said Mark Bertolini, CEO of Oscar Health. "We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners." Oscar is reaffirming its full year 2025 outlook across all metrics as provided in its financial results press release dated February 4, 2025. First Qu

      5/7/25 6:00:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health, Inc. 2025 First Quarter Earnings Conference Call

      Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless

      4/9/25 8:00:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

      With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX Ventures with participation from Floating Point, Thiel Bio, Founders Fund, Bertelsmann Investments, and existing investors, Giant Ventures and Obvious Ventures. The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE:OSCR), Ryan Fukushima, COO of Tempus, and others. Leading researchers from OpenAI and DeepMin

      3/5/25 2:13:00 PM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Leadership Updates

    Live Leadership Updates

    See more
    • Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

      Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York

      1/26/24 8:00:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team

      Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023. In her role, Sain oversees the go-to-market strategy for the +Oscar business and will work closely with Mario Schlosser, President of Technology and Chief Technology Officer, to continue externa

      9/6/23 8:30:00 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health, Inc. Appoints Dr. Sean Martin, MD as New Chief Medical Officer

      Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including enterprise affordability, medical management, market performance, population health, and behavioral health. In his new role, he will be responsible for implementing Oscar's clinical capabilities and enhancing the quality of care and outcomes for its members. "Dr. Martin is an avid champion of the us

      3/15/23 8:30:00 AM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    SEC Filings

    See more
    • SEC Form 144 filed by Oscar Health Inc.

      144 - Oscar Health, Inc. (0001568651) (Subject)

      5/12/25 4:09:55 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Oscar Health Inc.

      10-Q - Oscar Health, Inc. (0001568651) (Filer)

      5/7/25 7:11:20 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Oscar Health, Inc. (0001568651) (Filer)

      5/7/25 6:24:47 AM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Oscar Health Inc.

      SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)

      11/14/24 4:07:27 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Oscar Health Inc.

      SC 13G - Oscar Health, Inc. (0001568651) (Subject)

      11/14/24 1:28:35 PM ET
      $OSCR
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Oscar Health Inc.

      SC 13D/A - Oscar Health, Inc. (0001568651) (Subject)

      11/13/24 9:24:55 PM ET
      $OSCR
      Medical Specialities
      Health Care

    $OSCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Oscar Health downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Oscar Health from Overweight to Equal Weight and set a new price target of $16.00 from $20.00 previously

      3/13/25 8:18:37 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Jefferies initiated coverage on Oscar Health with a new price target

      Jefferies initiated coverage of Oscar Health with a rating of Underperform and set a new price target of $12.00

      12/10/24 7:59:30 AM ET
      $OSCR
      Medical Specialities
      Health Care
    • Oscar Health downgraded by BofA Securities with a new price target

      BofA Securities downgraded Oscar Health from Neutral to Underperform and set a new price target of $13.50 from $21.00 previously

      11/6/24 7:54:31 AM ET
      $OSCR
      Medical Specialities
      Health Care